ProfileGDS4718 / 1553009_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 24% 22% 25% 23% 21% 25% 27% 29% 29% 22% 19% 32% 27% 23% 28% 20% 27% 30% 23% 23% 28% 22% 23% 20% 27% 19% 31% 19% 27% 24% 28% 23% 21% 29% 22% 24% 27% 26% 23% 21% 28% 22% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2098221
GSM549102patient 115, normal, homogenized [OPG study]4.323824
GSM549104patient 119, normal, homogenized [OPG study]4.2082422
GSM549108patient 138, normal, homogenized [OPG study]4.3603725
GSM549119patient 077, normal, homogenized [OPG study]4.2734823
GSM549133patient 032, cancer, homogenized [OPG study]4.1278721
GSM549139patient 042, cancer, homogenized [OPG study]4.3354225
GSM549099patient 107, normal, homogenized [OPG study]4.4209627
GSM549109patient 139, normal, homogenized [OPG study]4.5199829
GSM549110patient 046, normal, homogenized [OPG study]4.4847829
GSM549114patient 063, normal, homogenized [OPG study]4.1768722
GSM549122patient 082, normal, homogenized [OPG study]4.1244519
GSM549134patient 033, cancer, homogenized [OPG study]4.6124932
GSM549136patient 036, cancer, homogenized [OPG study]4.368327
GSM549140patient 044, cancer, homogenized [OPG study]4.2217923
GSM549111patient 047, normal, homogenized [OPG study]4.431828
GSM549113patient 057, normal, homogenized [OPG study]4.1120620
GSM549132patient 031, cancer, homogenized [OPG study]4.4218327
GSM549137patient 038, cancer, homogenized [OPG study]4.5289330
GSM549142patient 047, cancer, homogenized [OPG study]4.3761923
GSM549100patient 110, normal, homogenized [OPG study]4.2760123
GSM549107patient 135, normal, homogenized [OPG study]4.4102828
GSM549115patient 068, normal, homogenized [OPG study]4.1842122
GSM549116patient 072, normal, homogenized [OPG study]4.2506923
GSM549120patient 078, normal, homogenized [OPG study]4.1213520
GSM549131patient 030, cancer, homogenized [OPG study]4.3525427
GSM549118patient 074, normal, homogenized [OPG study]4.120519
GSM549129patient 027, cancer, homogenized [OPG study]4.583231
GSM549123patient 088, normal, homogenized [OPG study]4.1051319
GSM549124patient 006, cancer, homogenized [OPG study]4.4740627
GSM549126patient 015, cancer, homogenized [OPG study]4.299624
GSM549128patient 025, cancer, homogenized [OPG study]4.4526128
GSM549103patient 117, normal, homogenized [OPG study]4.3083423
GSM549117patient 073, normal, homogenized [OPG study]4.1681621
GSM549138patient 041, cancer, homogenized [OPG study]4.4716729
GSM549141patient 045, cancer, homogenized [OPG study]4.1515522
GSM549130patient 028, cancer, homogenized [OPG study]4.3200324
GSM549101patient 111, normal, homogenized [OPG study]4.4286727
GSM549105patient 128, normal, homogenized [OPG study]4.405126
GSM549106patient 134, normal, homogenized [OPG study]4.2165123
GSM549112patient 048, normal, homogenized [OPG study]4.194621
GSM549125patient 011, cancer, homogenized [OPG study]4.4512128
GSM549127patient 024, cancer, homogenized [OPG study]4.209722
GSM549135patient 035, cancer, homogenized [OPG study]4.4011228